Glenmark Pharma Gets Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
Glenmark Pharma received final approval from USFDA for Tacrolimus capsules, which are used as immunosuppressants to prevent human immune system from rejecting liver, kidney and heart transplants.